glp-1 7-37 GLP-1(7-37) acetate Figure 2 from Featured Insulin-like

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been pivotal for obesity treatment, achieving 1525 % weight loss over 1224 months, but questions remain about the potential influence of concomitant losses in muscle mass

Smiley Aesthetics offers physician-supervised medical weight loss in Nashville using the latest treatments including Semaglutide and Tirzepatide

GLP-1 agonists are powerful weight loss tools, but certain medications can reduce their effectiveness or cause harmful interactions

Canada's new obesity guidelines signal a shift in food consumption, with GLP-1 drugs impacting how and what Canadiansespecially youtheat.

See how ADA and NICE compare on screening, glycemic targets, CGM, and the latest treatment strategies for real-world practice

A key part of the formulation of this beverage influences how full you feel after eating